uric acid has been researched along with Prostatic Hyperplasia in 9 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The relationship between uric acid (UA) and benign prostatic hyperplasia (BPH) is controversial and has rarely been studied in American populations." | 8.31 | Association of serum uric acid levels with benign prostatic hyperplasia in US men: results from NHANES 2005-2008. ( Hao, X; Liu, X; Pan, Y; Xu, M; Xu, Z; Zhou, H, 2023) |
| "Cinnamaldehyde, which is a major constituent in the essential oil of cinnamon, has been previously reported to reduce xanthine oxidase activity, in addition to its anti-inflammatory, anti-oxidant, and anti-proliferative activities." | 5.56 | The modulatory effects of cinnamaldehyde on uric acid level and IL-6/JAK1/STAT3 signaling as a promising therapeutic strategy against benign prostatic hyperplasia. ( Abdel-Rahman, HM; Abo-Youssef, AM; Afify, H; Allam, S; Azouz, AA, 2020) |
| "The relationship between uric acid (UA) and benign prostatic hyperplasia (BPH) is controversial and has rarely been studied in American populations." | 4.31 | Association of serum uric acid levels with benign prostatic hyperplasia in US men: results from NHANES 2005-2008. ( Hao, X; Liu, X; Pan, Y; Xu, M; Xu, Z; Zhou, H, 2023) |
| "Cinnamaldehyde, which is a major constituent in the essential oil of cinnamon, has been previously reported to reduce xanthine oxidase activity, in addition to its anti-inflammatory, anti-oxidant, and anti-proliferative activities." | 1.56 | The modulatory effects of cinnamaldehyde on uric acid level and IL-6/JAK1/STAT3 signaling as a promising therapeutic strategy against benign prostatic hyperplasia. ( Abdel-Rahman, HM; Abo-Youssef, AM; Afify, H; Allam, S; Azouz, AA, 2020) |
| "Uric acid urolithiasis was predominant in men in this study." | 1.35 | Local factors compared with systemic factors in the formation of bladder uric acid stones. ( Chou, YH; Huang, CH; Huang, SP; Li, CC; Li, WM; Liu, CC; Wu, WJ, 2009) |
| "In conclusion, the data suggest that NIDDM, hypertension, tallness, obesity, high insulin and low HDL cholesterol levels constitute risk factors for the development of BPH." | 1.30 | Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia. ( Hammarsten, J; Högstedt, B, 1999) |
| "The disorders associated with bladder stones were prostatic hyperplasia and cancer (47." | 1.29 | Chemical compositions of 300 lower urinary tract calculi and associated disorders in the urinary tract. ( Honda, M; Hosoya, Y; Imai, T; Maeda, S; Suzuki, T; Takasaki, E, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, H | 1 |
| Xu, M | 1 |
| Hao, X | 1 |
| Xu, Z | 1 |
| Pan, Y | 1 |
| Liu, X | 1 |
| Afify, H | 1 |
| Abo-Youssef, AM | 1 |
| Abdel-Rahman, HM | 1 |
| Allam, S | 1 |
| Azouz, AA | 1 |
| Siroosbakht, S | 1 |
| Rezakhaniha, S | 1 |
| Namdari, F | 1 |
| Rezakhaniha, B | 1 |
| Li, WM | 1 |
| Chou, YH | 1 |
| Li, CC | 1 |
| Liu, CC | 1 |
| Huang, SP | 1 |
| Wu, WJ | 1 |
| Huang, CH | 1 |
| Takasaki, E | 1 |
| Suzuki, T | 1 |
| Honda, M | 1 |
| Imai, T | 1 |
| Maeda, S | 1 |
| Hosoya, Y | 1 |
| Hammarsten, J | 1 |
| Högstedt, B | 1 |
| Aboulker, P | 1 |
| Thomas, J | 1 |
| Oursin, P | 1 |
| Pintér, J | 1 |
| Wölfer, E | 1 |
9 other studies available for uric acid and Prostatic Hyperplasia
| Article | Year |
|---|---|
Association of serum uric acid levels with benign prostatic hyperplasia in US men: results from NHANES 2005-2008.
Topics: Humans; Hypertension; Male; Nutrition Surveys; Prostatic Hyperplasia; Risk Factors; United States; U | 2023 |
The modulatory effects of cinnamaldehyde on uric acid level and IL-6/JAK1/STAT3 signaling as a promising therapeutic strategy against benign prostatic hyperplasia.
Topics: Acrolein; Animals; Biomarkers; Cell Proliferation; Cyclin D1; Gene Expression Regulation; Immunohist | 2020 |
Is there relationship between serum uric acid levels and lower urinary tract symptoms, prostate volume, and PSA in men without cancer? A prospective population-based study.
Topics: Aged; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Neoplasms; Prospective Studies; Prost | 2021 |
Local factors compared with systemic factors in the formation of bladder uric acid stones.
Topics: Adult; Aged; Aged, 80 and over; Creatinine; Diabetes Complications; Female; Humans; Hydrogen-Ion Con | 2009 |
Chemical compositions of 300 lower urinary tract calculi and associated disorders in the urinary tract.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteriuria; Calcium Oxalate; Calcium Phosphates; Chi-Sq | 1995 |
Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia.
Topics: Aged; Aged, 80 and over; Alanine Transaminase; Arteriosclerosis; Blood Pressure; Body Height; Body M | 1999 |
[Urinary tract infection, hyperuricemia, septicemia, transitory abdominal pain, cerebral accident].
Topics: Aged; Ascites; Cerebrovascular Disorders; Cystitis; Hemiplegia; Humans; Liver Cirrhosis; Male; Prost | 1970 |
[Dissolution of vesical uric acid calculi].
Topics: Aged; Alkalies; Anti-Infective Agents, Urinary; Benzothiadiazines; Bicarbonates; Citrates; Humans; M | 1967 |
[Current problems of the uremic syndrome].
Topics: Adult; Blood Urea Nitrogen; Chronic Disease; Creatinine; Female; Humans; Male; Nephritis; Prognosis; | 1969 |